CASTLE BIOSCIENCES, INC. Other Noncash Income (Expense)
CASTLE BIOSCIENCES, INC. (CSTL) reported Other Noncash Income (Expense) of -$767.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2026-06-30 was -$235.00K.
- CASTLE BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$532.00K.
- CASTLE BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2025-12-31 was $129.00K.
- CASTLE BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$63.00K.
- CASTLE BIOSCIENCES, INC. other noncash income (expense) for fiscal 2025 was -$153.00K.
- CASTLE BIOSCIENCES, INC. other noncash income (expense) for fiscal 2024 was -$268.00K.
- CASTLE BIOSCIENCES, INC. other noncash income (expense) for fiscal 2023 was -$635.00K.
- CASTLE BIOSCIENCES, INC. other noncash income (expense) for fiscal 2022 was -$158.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$767.00K 10-Q · filed 2026-07-30 | -$638.00K derived: sum of 3 quarters · filed 2026-07-30 | -$701.00K derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | -$532.00K 10-Q · filed 2026-05-06 | -$403.00K derived: sum of 2 quarters · filed 2026-05-06 | -$466.00K derived: sum of 3 quarters · filed 2026-05-06 | -$655.00K derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $66.00K derived: sum of 2 quarters · filed 2026-02-26 | -$123.00K derived: sum of 3 quarters · filed 2026-07-30 | -$153.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$252.00K derived: sum of 2 quarters · filed 2026-07-30 | -$282.00K 10-Q · filed 2025-11-03 | -$342.00K derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | -$189.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$219.00K 10-Q · filed 2026-07-30 | -$279.00K derived: sum of 3 quarters · filed 2026-07-30 | -$404.00K derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | -$30.00K 10-Q · filed 2026-05-06 | -$90.00K derived: sum of 2 quarters · filed 2026-05-06 | -$215.00K derived: sum of 3 quarters · filed 2026-05-06 | -$119.00K derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$185.00K derived: sum of 2 quarters · filed 2026-02-26 | -$89.00K derived: sum of 3 quarters · filed 2026-02-26 | -$268.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$29.00K derived: sum of 2 quarters · filed 2025-11-03 | -$208.00K 10-Q · filed 2025-11-03 | -$559.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$83.00K 10-Q · filed 2025-08-04 | -$434.00K derived: sum of 3 quarters · filed 2026-02-26 | -$505.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$179.00K 10-Q · filed 2025-05-05 | -$530.00K derived: sum of 2 quarters · filed 2026-02-26 | -$601.00K derived: sum of 3 quarters · filed 2026-02-26 | -$603.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$422.00K derived: sum of 2 quarters · filed 2026-02-26 | -$424.00K derived: sum of 3 quarters · filed 2026-02-26 | -$635.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$73.00K derived: sum of 2 quarters · filed 2024-11-04 | -$284.00K 10-Q · filed 2024-11-04 | -$256.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$213.00K 10-Q · filed 2024-08-05 | -$185.00K derived: sum of 3 quarters · filed 2025-02-27 | -$332.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | -$211.00K 10-Q · filed 2024-05-02 | -$183.00K derived: sum of 2 quarters · filed 2025-02-27 | -$330.00K derived: sum of 3 quarters · filed 2025-02-27 | -$357.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$119.00K derived: sum of 2 quarters · filed 2025-02-27 | -$146.00K derived: sum of 3 quarters · filed 2025-02-27 | -$158.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$174.00K derived: sum of 2 quarters · filed 2023-11-02 | -$186.00K 10-Q · filed 2023-11-02 | -$285.00K derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$39.00K 10-Q · filed 2023-08-02 | -$138.00K derived: sum of 3 quarters · filed 2023-08-02 | $30.00K derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-03-31 | -$12.00K 10-Q · filed 2023-05-03 | -$111.00K derived: sum of 2 quarters · filed 2023-05-03 | $57.00K derived: sum of 3 quarters · filed 2023-05-03 | $21.00K derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | -$99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $69.00K derived: sum of 2 quarters · filed 2023-02-28 | $33.00K derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | |
| 2021-09-30 | $168.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $132.00K derived: sum of 2 quarters · filed 2022-11-02 | $99.00K 10-Q · filed 2022-11-02 | $118.00K derived: sum of 4 quarters · filed 2022-11-02 | |
| 2021-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$69.00K 10-Q · filed 2022-08-08 | -$50.00K derived: sum of 3 quarters · filed 2022-08-08 | -$53.00K derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | -$33.00K 10-Q · filed 2022-05-09 | -$14.00K derived: sum of 2 quarters · filed 2022-05-09 | -$17.00K derived: sum of 3 quarters · filed 2022-05-09 | -$17.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $16.00K derived: sum of 2 quarters · filed 2022-02-28 | $16.00K derived: sum of 3 quarters · filed 2022-02-28 | $16.00K 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$3.00K derived: sum of 2 quarters · filed 2021-11-08 | -$3.00K 10-Q · filed 2021-11-08 | -$3.00K derived: sum of 4 quarters · filed 2021-11-08 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $0.00 derived: sum of 3 quarters · filed 2021-08-09 | $337.00 derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2021-05-10 | $337.00 derived: sum of 3 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $337.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $337.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | -$337.00 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | -$337.00 10-Q · filed 2019-09-03 | ||||
| 2018-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $24.00K derived: sum of 2 quarters · filed 2020-03-10 | $24.00K 10-K · filed 2020-03-10 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |